Search

Alcohol use is a leading risk factor for premature death and disability. To tackle this issue, more systematic and accurate screening for at-risk consumption is needed in healthcare systems, especially by general practitioners (GPs). We assessed the frequency of at-risk consumption screening by GPs in France. We also identified characteristics associated with more frequent screening and greater use of validated screening tools by these healthcare providers. A cross-sectional survey was conducted among a representative sample of French GPs. Multinomial logistic regressions were used to identify factors associated with more frequent screening and greater use of validated screening tools. Response rate was of 73%. Of the 2412 participants, 42.8% screened all their patients systematically and repeatedly, while 48.0% never used standardized tools to screen potentially at-risk patients. Among other characteristics, being aware of and using the "early identification and brief intervention" screening strategy, and feeling absolutely comfortable talking with patients about reducing or stopping their alcohol use, were both associated with more frequent screening and use of standardized tools. Our results on at-risk alcohol use screening highlight an improvement over data from previous studies. Nevertheless, better training of French GPs in good alcohol screening practices—specifically, increased screening frequency and greater use of standardized tools—may improve identification of at-risk patients. [ABSTRACT FROM AUTHOR]

This document is a correction notice for an article titled "Social and professional recognition are key determinants of quality of life at work among night-shift healthcare workers in Paris public hospitals (AP-HP ALADDIN COVID-19 survey)" published in the journal PLoS ONE. The correction addresses errors in the author affiliations. The correct affiliations are provided for Martin Duracinsky, Fabienne Marcellin, Lorraine Cousin, Vincent Di Beo, Véronique Mahé, Olivia Rousset-Torrente, Patrizia Carrieri, and Olivier Chassany. The correction notice does not provide any additional information about the content of the article. [Extracted from the article]

The article examines the association between cannabis use and undetectable plasma human immunodeficiency virus (HIV) RNA levels from male patients coinfected with HIV and hepatitis C virus receiving antiretroviral therapy (ART) based on a study by Chaillon et al. The study identified the effect of cannabis use on the HIV reservoir during ART among male patients. Analysis of sociobehavioral and clinical data revealed no link between the frequency of cannabis use and plasma HIV viral load.